Do anti-TNF-α drugs increase cancer risk in rheumatoid arthritis patients?

被引：3
|
作者：
Clark, David A. [1 ,2 ]
机构：
[1] McMaster Univ, Dept Med, Hlth Sci Ctr Rm 3H1E, Hamilton, ON L8S 4K1, Canada
[2] Univ Toronto, Fac Med, Dept Immunol, Toronto, ON, Canada
来源：
INFLAMMOPHARMACOLOGY | 2013年 / 21卷 / 02期
关键词：
Rheumatoid arthritis; Anti-tumor necrosis factor-alpha; Cancer; Meta-analysis; NECROSIS-FACTOR INHIBITORS; MALIGNANCIES; METAANALYSIS; REGISTRY; THERAPY;
D O I：
10.1007/s10787-012-0158-0
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Concern has been raised about an increased risk of lymphoma and skin cancers in patients with rheumatoid arthritis due to administration of anti-TNF-alpha drugs. Meta-analysis of observational data from registries as well as from randomized controlled trials has failed to show a significant increase in the risk of lymphoma when the sample size has been sufficiently large; skin cancer risk may represent a valid concern. Issues relating to interpretation of these data are discussed.
引用
收藏
页码：125 / 127
页数：3
相关论文
共 50 条
  • [21] Optimizing withdrawal strategies for anti-TNF-α therapies in rheumatoid arthritis
    Venetsanopoulou, Aliki, I
    Voulgari, Paraskevi V.
    Drosos, Alexandros A.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2024, 24 (08) : 815 - 825
  • [22] Insulin resistance in rheumatoid arthritis: the impact of the anti-TNF-α therapy
    Gonzalez-Gay, Miguel A.
    Gonzalez-Juanatey, Carlos
    Vazquez-Rodriguez, Tomas R.
    Miranda-Filloy, Jose A.
    Llorca, Javier
    NEUROENDOCRINE IMMUNOLOGY IN RHEUMATIC DISEASES: TRANSLATION FROM BASICS TO CLINICS, 2010, 1193 : 153 - 159
  • [23] Unstable diabetes in a patient receiving anti-TNF-α for rheumatoid arthritis
    Boulton, J. G.
    Bourne, J. T.
    RHEUMATOLOGY, 2007, 46 (01) : 178 - 179
  • [24] Different switching rate of anti-TNF-α drugs in monotherapy and in combination with methotrexate in a cohort of rheumatoid arthritis patients in the real life
    Iannone, Florenzo
    Notarnicola, Antonella
    Lopalco, Giuseppe
    Lapadula, Giovanni
    JOINT BONE SPINE, 2014, 81 (05) : 458 - 459
  • [25] Do non-steroidal anti-inflammatory drugs increase or decrease cardiovascular risk in patients with rheumatoid arthritis?
    Sfikakis, P. P.
    Bournia, V. -K.
    Kitas, G.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (06) : S8 - S9
  • [26] Cardiovascular risk in rheumatoid arthritis: effects of anti-TNF drugs
    Avouac, J.
    Allanore, Y.
    EXPERT OPINION ON PHARMACOTHERAPY, 2008, 9 (07) : 1121 - 1128
  • [27] Rheumatoid arthritis (RA) patients on tumor necrosis factor (TNF) blockers do not have an increase in risk of cancer.
    Maury, EE
    Reed, G
    Cassell, S
    Kavanaugh, A
    Kremer, J
    Hochberg, M
    ARTHRITIS AND RHEUMATISM, 2005, 52 (12): : 4055 - 4055
  • [28] No effect of anti-TNF-α treatment on serum IL-17 in patients with rheumatoid arthritis
    Sikorska, Dorota
    Rutkowski, Rafal
    Luczak, Joanna
    Samborski, Wlodzimierz
    Witowski, Janusz
    CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY, 2018, 43 (03) : 270 - 275
  • [29] Bone metabolism changes during anti-TNF-α therapy in patients with active rheumatoid arthritis
    Seriolo, Bruno
    Paolino, Sabrina
    Sulli, Alberto
    Ferretti, Valentino
    Cutolo, Maurizio
    BASIC AND CLINICAL ASPECTS OF NEUROENDOCRINE IMMUNOLOGY IN RHEUMATIC DISEASES, 2006, 1069 : 420 - 427
  • [30] Biological Anti-TNF-α Therapy and Markers of Oxidative and Carbonyl Stress in Patients with Rheumatoid Arthritis
    Stenova, Emoke
    Bakosova, Martina
    Laukova, Lucia
    Celec, Peter
    Vlkova, Barbora
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2021, 2021
12345